
Castle Biosciences is a diagnostics & research business based in the US. Castle Biosciences shares (CSTL) are listed on the NASDAQ and all prices are listed in US Dollars. Castle Biosciences employs 517 staff and has a trailing 12-month revenue of around $123.7 million.
How to buy Castle Biosciences stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – CSTL. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Castle Biosciences stock price (NASDAQ: CSTL)
Use our graph to track the performance of CSTL stocks over time.Castle Biosciences shares at a glance
Latest market close | $26.54 |
---|---|
52-week range | $15.58 - $48.40 |
50-day moving average | $23.37 |
200-day moving average | $24.59 |
Wall St. target price | $49.50 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.04 |
Buy Castle Biosciences stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Castle Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Castle Biosciences price performance over time
Historical closes compared with the close of $26.54 from 2023-01-25
1 week (2023-01-20) | -0.38% |
---|---|
1 month (2022-12-23) | N/A |
3 months (2022-10-26) | 19.39% |
6 months (2022-07-23) | N/A |
1 year (2022-01-27) | -25.37% |
---|---|
2 years (2021-01-27) | -59.04% |
3 years (2020-01-27) | 30 |
5 years (2018-01-23) | N/A |
Castle Biosciences financials
Revenue TTM | $123.7 million |
---|---|
Gross profit TTM | $78.3 million |
Return on assets TTM | -11.66% |
Return on equity TTM | -12.87% |
Profit margin | -42.79% |
Book value | $15.61 |
Market capitalisation | $699.6 million |
TTM: trailing 12 months
Castle Biosciences share dividends
We're not expecting Castle Biosciences to pay a dividend over the next 12 months.
Castle Biosciences share price volatility
Over the last 12 months, Castle Biosciences's shares have ranged in value from as little as $15.58 up to $48.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Castle Biosciences's is 0.9975. This would suggest that Castle Biosciences's shares are less volatile than average (for this exchange).
Castle Biosciences overview
Castle Biosciences, Inc. , a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas. .
Castle Biosciences in the news
Castle Biosciences’ Medical Director to Present at the Precision Medicine World Conference 2023

Data Presentations at 2023 Winter Clinical Dermatology Conference - Hawaii® Support Clinical Value of Castle Biosciences’ Skin Cancer Test Portfolio

Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2022 Results
Frequently asked questions
What percentage of Castle Biosciences is owned by insiders or institutions?Currently 4.802% of Castle Biosciences shares are held by insiders and 84.287% by institutions. How many people work for Castle Biosciences?
Latest data suggests 517 work at Castle Biosciences. When does the fiscal year end for Castle Biosciences?
Castle Biosciences's fiscal year ends in December. Where is Castle Biosciences based?
Castle Biosciences's address is: 505 South Friendswood Drive, Friendswood, TX, United States, 77546 What is Castle Biosciences's ISIN number?
Castle Biosciences's international securities identification number is: US14843C1053 What is Castle Biosciences's CUSIP number?
Castle Biosciences's Committee on Uniform Securities Identification Procedures number is: 14843C105
More guides on Finder
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
-
Best international stock brokers for 2023
We explore some of the best brokerage accounts for international stock trading. Here’s what you need to know.
Ask an Expert